Monoclonal Antibody Therapy to Treat COVID-19

PLEASE NOTE: The Food and Drug Administration has removed the ability for any state to administer Regeneron’s REGEN-COV or Eli Lilly’s Bamlanivimab and Etesevimab. As a result, we have had to cancel appointments at our CDR Health Tallahassee Clinic location, in addition to our public sites. Please visit HealthierYouFL.com for resources on emerging treatments. Pharmacies that have received allocations of antiviral treatments can be found at FloridaHealthCOVID19.gov. Please consult with your healthcare provider to discuss appropriate treatment options.

Monoclonal antibody therapy is a life-saving treatment used for COVID-19 and is administered via subcutaneous injections or IV infusion.

 

For use in adults and pediatric patients (12 years and older)
Covid-19 patient
For high-risk patients who have been exposed to COVID-19, monoclonal antibody therapy can reduce the risk of severe disease, hospitalization, and death by 70%, and decreases your odds of infection by over 80%—or if you are infected, reduce the length of COVID-19 symptoms by four days, on average. Direct access to early treatment is essential to saving lives.
OPEN MAB TREATMENT FLYER

DO YOU NEED TESTING, VACCINATION, OR MONOCLONAL ANTIBODY TREATMENT SERVICES?

BENEFITS OF RECEIVING MONOCLONAL ANTIBODY TREATMENT IN OUR CLINIC

Ability to schedule an appointment and avoid long wait-times

Receive quality care by industry leaders in pandemic response

Receive treatment in private, at our state-of-the-art facility

Easily schedule a Telehealth session to follow-up on treatment and recovery

Insurance Accepted.

WANT TO LEARN MORE ABOUT TESTING, VACCINATIONS OR TELEHEALTH SERVICES?